Syntheses of HIV-protease inhibitors having a peptide moiety which binds to GP120

Chemical and Pharmaceutical Bulletin

Volumn 46, Issue 4, 1998, Pages 697-703

  Asagarasu, Akira ^a   Uchiyama, Taketo ^a   Achiwa, Kazuo ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

CPF; gp120; HIV; Protease inhibitor

Indexed keywords

3 AMINO 2 HYDROXY 4 PHENYLBUTYRIC ACID; BENZOIC ACID ESTER DERIVATIVE; CARBONYL DERIVATIVE; GLYCOPROTEIN GP 120; PEPTIDE DERIVATIVE; PHENOXYACETIC ACID DERIVATIVE; PHENYLALANINE; PROPANE; PROTEINASE INHIBITOR; TRIFLUOROACETIC ACID;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG BINDING SITE; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; VIRUS INHIBITION;

EID: 0031967809     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.46.697     Document Type: Article

References (17)

1. McDougal J. S., Kennedy M. S., Sligh J. M., Cort S. P., Mawle A., Nicholson J. K. A., Science, 231(4736), 382-385 (1986).
2. Bowman M. R., Macferrin K. D., Schreiber S. L., Burakoff S. J., Proc. Natl. Acad. Sci. U.S.A., 87(22), 9052-9056 (1990).
3. a) Finberg R. W., Diamond D. C., Mitchell D. B., Rosentein Y., Soman G., Norman T. C., Schreiber S. L., Burakoff S. J., Science, 249(4966), 287-291 (1990);
4. b) Venkatramani L., Hossain M. B., Van der Helm D., Int. J. Pept. Prot. Res., 43(6), 520-528 (1994).
5. Uchiyama T., Yoshino H., Takemoto M., Achiwa K., Chem. Pharm. Bull., 39(11), 3091-3093 (1991).
6. Huff J. R., J. Med. Chem., 34(8), 2305-2314 (1991).
7. a) Mimoto T., Imai J., Tanaka S., Hattori N., Kasanuki S., Akaji K., Kiso Y., Chem. Pharm. Bull., 39(11), 3088-3090 (1991);
8. b) Mimoto T., Imai J., Kasanuki S., Mimoto H., Hattori N., Akaji K., Kiso Y., ibid., 40(8), 2251-2253 (1992);
9. c) Kiso Y., Biopolymers, 40(2), 235-244 (1996).
10. Takita T., Suda H., Aoyagi T., Umezawa H., J. Med. Chem., 20(4), 510-515 (1977).
11. Rich D. H., Jasensky R. D., Mueller G. C., Andersen K. E., J. Med. Chem., 24(5), 567-572 (1981).
12. a) Ninomiya K., Shioiri T., Yamada S., Chem. Pharm. Bull., 24(11), 2711-2715 (1976);
13. b) Hamada Y., Rishi S., Shioiri T., Yamada S., ibid., 25(2), 224-230 (1977).
14. Ikeda K., Asahara T., Achiwa K., Hoshino H., Chem. Pharm. Bull., 45(2), 402-405 (1997); The biological activities will be reported separately by Prof. Hiroo Hoshino et al. (Gunma Univ.).
15. The assay was carried out by Central Research Laboratories of Mercian Corporation.
16. a) Bures L., Bostik J., Motycka K., Spundova M., Rehak L., Neoplasma, 35(3), 329-342 (1988);
17. b) Bures L., Lichy A., Bostik J., Spundova M., ibid., 37(3), 225-231 (1990).